FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
This celebrity-approved SBLA anti-aging eye treatment is 40% off ahead of Black Friday — 'it really works,' say shoppers
Aging is undoubtedly a natural part of life, and while some embrace what time does to their skin, others might look for a ...